All-Yu Biotech-KY Announces Scheduled Board Meeting on May 13, 2026 to Approve Q1 2026 Consolidated Financial Report
Key facts
- All-Yu Biotech-KY Announces Scheduled Board Meeting on May 13, 2026 to Approve Q1 2026 Consolidated Financial Report
- All-Yu Biotech-KY announced that a board meeting is scheduled for May 13, 2026, to approve its Q1 2026 consolidated financial report. This is part of the company's regular financial disclosure process.
- Source: PR Times
- Date: May 5, 2026
Direct answer
All-Yu Biotech-KY announced that a board meeting is scheduled for May 13, 2026, to approve its Q1 2026 consolidated financial report. This is part of the company's regular financial disclosure process.
- Citation
- All-Yu Biotech-KY Announces Scheduled Board Meeting on May 13, 2026 to Approve Q1 2026 Consolidated Financial Report (May 5, 2026), PR Times
- Source
- PR Times
- Date
- May 5, 2026
All-Yu Biotech-KY announced that a board meeting is scheduled for May 13, 2026, to approve its Q1 2026 consolidated financial report. This is part of the company's regular financial disclosure process.
📋 Article Processing Timeline
- 📰 Published: May 5, 2026 at 09:00
- 🔍 Collected: May 6, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 6, 2026 at 08:27 (27 min after Collected)
1. Date of board meeting convocation notice: 115/05/05
2. Estimated date of board meeting: 115/05/13
3. Financial report or annual self-compiled financial information quarter to be submitted to the board or resolved by the board: Q1 2026 Consolidated Financial Report
4. Other matters that should be specified: None
Keywords: Material Information
2. Estimated date of board meeting: 115/05/13
3. Financial report or annual self-compiled financial information quarter to be submitted to the board or resolved by the board: Q1 2026 Consolidated Financial Report
4. Other matters that should be specified: None
Keywords: Material Information
FAQ
What are the key facts in this article?
All-Yu Biotech-KY announced that a board meeting is scheduled for May 13, 2026, to approve its Q1 2026 consolidated financial report. This is part of the company's regular financial disclosure process.
What is the direct answer?
All-Yu Biotech-KY announced that a board meeting is scheduled for May 13, 2026, to approve its Q1 2026 consolidated financial report. This is part of the company's regular financial disclosure process.
What is the source and date?
PR Times: https://mops.twse.com.tw/material/twse-4148-2026-05-05-04226c8d | May 5, 2026